In severe alcoholic hepatitis, serum keratin-18 fragments are diagnostic, prognostic, and theragnostic biomarkers.
File(s)In_Severe_Alcoholic_Hepatitis,_Serum_Keratin_18.21.pdf (1.18 MB)
Published version
Author(s)
Type
Journal Article
Abstract
INTRODUCTION: Up to 40% of patients with severe alcoholic hepatitis (AH) die within 6 months of presentation, making prompt diagnosis and appropriate treatment essential. We determined the associations between serum keratin-18 (K18) and histological features, prognosis, and differential response to prednisolone in patients with severe AH. METHODS: Total (K18-M65) and caspase-cleaved K18 (K18-M30) were quantified in pretreatment sera from 824 patients enrolled in the Steroids or Pentoxifylline for Alcoholic Hepatitis trial (87 with suitable histological samples) and disease controls. RESULTS: K18 fragments were markedly elevated in severe AH and strongly predicted steatohepatitis (alcoholic steatohepatitis) on biopsy (area under receiver operating characteristics: 0.787 and 0.807). Application of published thresholds to predict alcoholic steatohepatitis would have rendered biopsy unnecessary in 84% of all AH cases. K18-M30 and M65 were associated with 90-day mortality, independent of age and Model for End-stage Liver Disease score in untreated patients. The association for K18-M65 was independent of both age and Model for End-stage Liver Disease in prednisolone-treated patients. Modelling of the effect of prednisolone on 90-day mortality as a function of pretreatment serum K18 levels indicated benefit in those with high serum levels of K18-M30. At low pretreatment serum K18 levels, prednisolone was potentially harmful. A threshold of K18-M30 5 kIU/L predicted therapeutic benefit from prednisolone above this level (odds ratio: 0.433, 95% confidence interval: 0.19-0.95, P = 0.0398), but not below (odds ratio: 1.271, 95% confidence interval: 0.88-1.84, P = 0.199). Restricting prednisolone usage to the former group would have reduced exposure by 87%. DISCUSSION: In a large cohort of patients with severe AH, serum K18 strongly correlated with histological severity, independently associated with 90-day mortality, and predicted response to prednisolone therapy. Quantification of serum K18 levels could assist in clinical decision-making.
Date Issued
2020-11
Date Acceptance
2020-06-19
Citation
American Journal of Gastroenterology, 2020, 115 (11), pp.1857-1868
ISSN
0002-9270
Publisher
Lippincott, Williams & Wilkins
Start Page
1857
End Page
1868
Journal / Book Title
American Journal of Gastroenterology
Volume
115
Issue
11
Copyright Statement
© 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited
and reproduction in any medium, provided the original work is properly cited
License URL
Sponsor
Wellcome Trust ISSF
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/33156105
PII: 00000434-202011000-00021
Grant Number
294834/Z/16/Z ISSF ICL
Subjects
1103 Clinical Sciences
Gastroenterology & Hepatology
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2020-10-02